Transaction · 0001193125-26-410839

Mainolfi Nello

Mainolfi Nello, CEO, reported an open-market or private sale at Kymera Therapeutics, Inc. involving 262.000000 shares for an estimated $30423.44. Reported holdings after the transaction were 666568.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCEO

KYMRKymera Therapeutics, Inc.

Filing timeOct 01

Trade dateOct 01, 2026

Filing · SECView on SEC

InsiderProfile

% of reported position traded0.04%Shares sold ÷ (holdings after + shares sold). Estimated position before: 666,830 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows

Price at filing

$110.12

Pre-filing

1mo ago +8.1%1w ago +5.2%1d ago +1.5%

Returns since

7d30d90d180d1y

KYMR price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards

KYMR since 2026-10-01Filed yesterday · 1 day of post-filing data

Loading…

Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative

Type: Sell
Identifier: 0001193125-26-410839
Transaction date: Oct 01, 2026
Shares: 262 sh
Estimated value: -$30.4k
Holdings after: 666k sh

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M

Direct Ownership Repeat Seller 10b5-1 Detected

0score

Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No

Footnotes & amended

F1
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.93 to $111.90, inclusive. The reporting person undertakes to pro…
F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.97 to $112.92 inclusive. The reporting person undertakes to prov…
F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.95 to $113.88 inclusive. The reporting person undertakes to prov…
F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.94 to $114.91 inclusive. The reporting person undertakes to prov…
F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.94 to $115.92, inclusive. The reporting person undertakes to pro…
F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.09 to $116.16 inclusive. The reporting person undertakes to prov…
F8
The shares underlying this stock option are fully vested and exercisable.

Original filing · 0001193125-26-410839

Related transactions

0 other filings

Same reporting owner

Recent company activity

0 recent txs

KYMR